All Stories

  1. Inhibition of Vps34 and p110δ PI3K Impairs Migration, Invasion and Three-Dimensional Spheroid Growth in Breast Cancer Cells
  2. New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models
  3. Targeting ERβ to fight melanoma: a new valid approach?
  4. A Small Peptide Targeting the Ligand-Induced Androgen Receptor/Filamin a Interaction Inhibits the Invasive Phenotype of Prostate Cancer Cells
  5. ERβ in Triple-Negative Breast Cancer: Emerging Concepts and Therapeutic Possibilities
  6. Exploiting the mechanism of estrogen-induced transcription to fight breast cancer
  7. Correction to: The androgen receptor/filamin A complex as a target in prostate cancer microenvironment
  8. The androgen receptor/filamin A complex as a target in prostate cancer microenvironment
  9. Role of the demethylase LSD-1 in cell functions
  10. Acetylation/methylation at lysine 9 in histone H3 as a mark of nucleosome asymmetry in human somatic breast cells
  11. Role of ROS generated by nuclear protein modification in the development of cancer
  12. Breast cancer stem cells: the role of sex steroid receptors
  13. Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer
  14. Nerve Growth Factor Induces Proliferation and Aggressiveness in Prostate Cancer Cells
  15. BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibition
  16. NGF Induces Proliferation and Aggressiveness In Prostate Cancer Cells.
  17. Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells Through AR/Src/PI3-K Complex Assembly
  18. Estrogens Modulate Somatostatin Receptors Expression and Synergize With the Somatostatin Analog Pasireotide in Prostate Cells
  19. The Androgen Receptor in Breast Cancer
  20. The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia
  21. Cross-talk between androgen receptor and nerve growth factor receptor in prostate cancer cells: implications for a new therapeutic approach
  22. Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation
  23. Inhibition of p110δ PI3K prevents inflammatory response and restenosis after artery injury
  24. Extranuclear partners of androgen receptor: at the crossroads of proliferation, migration, and neuritogenesis
  25. Recent advances on bisphenol-A and endocrine disruptor effects on human prostate cancer
  26. Faculty of 1000 evaluation for Progesterone receptor modulates ERα action in breast cancer.
  27. Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells
  28. Cross-talk between androgen receptor/filamin A and TrkA regulates neurite outgrowth in PC12 cells
  29. Role of JMJD6 in Breast Tumourigenesis
  30. Non-Genomic Androgen Action Regulates Proliferative/Migratory Signaling in Stromal Cells
  31. Faculty of 1000 evaluation for LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer.
  32. Role of non-genomic androgen signalling in suppressing proliferation of fibroblasts and fibrosarcoma cells
  33. Nuclear receptor-induced transcription is driven by spatially and timely restricted waves of ROS
  34. Expression of Autophagy-Related Proteins According to Androgen Receptor and HER-2 Status in Estrogen Receptor-Negative Breast Cancer
  35. Extremely Low-Frequency Electromagnetic Fields Cause G1 Phase Arrest through the Activation of the ATM-Chk2-p21 Pathway
  36. Epigenetic drugs against cancer: an evolving landscape
  37. Phosphorylation of H3 serine 10 by IKKα governs cyclical production of ROS in estrogen-induced transcription and ensures DNA wholeness
  38. A Firmer Understanding of the Effect of Hypergravity on Thyroid Tissue: Cholesterol and Thyrotropin Receptor
  39. Diversin Is Overexpressed in Breast Cancer and Accelerates Cell Proliferation and Invasion
  40. The Deficiency of Tumor Suppressor Prep1 Accelerates the Onset of Meis1- Hoxa9 Leukemogenesis
  41. Dissection of Estrogen Receptor Alpha Signaling Pathways in Osteoblasts Using RNA-Sequencing
  42. Metformin Inhibits Androgen-Induced IGF-IR Up-Regulation in Prostate Cancer Cells by Disrupting Membrane-Initiated Androgen Signaling
  43. Analysis of Histone Posttranslational Modifications in the Control of Chromatin Plasticity Observed at Estrogen-Responsive Sites in Human Breast Cancer Cells
  44. Phosphoinositide 3-Kinase Assay in Breast Cancer Cell Extracts
  45. Resveratrol Couples Apoptosis with Autophagy in UVB-Irradiated HaCaT Cells
  46. Nuclear Ras2-GTP Controls Invasive Growth in Saccharomyces cerevisiae
  47. Protein-Tyrosine Phosphatase H1 Increases Breast Cancer Sensitivity to Antiestrogens by Dephosphorylating Estrogen Receptor at Tyr537
  48. RTK/ERK Pathway under Natural Selection Associated with Prostate Cancer
  49. Targeting Androgen Receptor/Src Complex Impairs the Aggressive Phenotype of Human Fibrosarcoma Cells
  50. Correction: TACC3 Is Essential for EGF-Mediated EMT in Cervical Cancer
  51. Estradiol and Tamoxifen Induce Cell Migration through GPR30 and Activation of Focal Adhesion Kinase (FAK) in Endometrial Cancers with Low or without Nuclear Estrogen Receptor α (ERα)
  52. Differentially Expressed Androgen-Regulated Genes in Androgen-Sensitive Tissues Reveal Potential Biomarkers of Early Prostate Cancer
  53. Faculty of 1000 evaluation for FBXL2- and PTPL1-mediated degradation of p110-free p85β regulatory subunit controls the PI(3)K signalling cascade.
  54. Faculty of 1000 evaluation for Activation of mitogen- and stress-activated kinase 1 is required for proliferation of breast cancer cells in response to estrogens or progestins.
  55. Retinoic acid impairs estrogen signaling in breast cancer cells by interfering with activation of LSD1 via PKA
  56. Acetylcholine Acts on Androgen Receptor to Promote the Migration and Invasion but Inhibit the Apoptosis of Human Hepatocarcinoma
  57. Does Changing Androgen Receptor Status during Prostate Cancer Development Impact upon Cholesterol Homeostasis?
  58. Estradiol Receptor (ER) Chromatin Immunoprecipitation in MCF-7 Cells
  59. p130Cas Over-Expression Impairs Mammary Branching Morphogenesis in Response to Estrogen and EGF
  60. Faculty of 1000 evaluation for Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.
  61. The DEK Oncogene Is a Target of Steroid Hormone Receptor Signaling in Breast Cancer
  62. A Switch Role of Src in the Biphasic EGF Signaling of ER-Negative Breast Cancer Cells
  63. Polyproline and Tat transduction peptides in the study of the rapid actions of steroid receptors
  64. Neuregulin Promotes Incomplete Autophagy of Prostate Cancer Cells That Is Independent of mTOR Pathway Inhibition
  65. Nuclear Factor-Kappa B Inhibition Can Enhance Apoptosis of Differentiated Thyroid Cancer Cells Induced by 131I
  66. ALK-Activating Homologous Mutations in LTK Induce Cellular Transformation
  67. Faculty of 1000 evaluation for Estrogen receptor β exerts tumor repressive functions in human malignant pleural mesothelioma via EGFR inactivation and affects response to gefitinib.
  68. Faculty of 1000 evaluation for Differential oestrogen receptor binding is associated with clinical outcome in breast cancer.
  69. Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells
  70. Advances in Rapid Sex-Steroid Action
  71. Non-genomic Action of Steroid Hormones: More Questions than Answers
  72. Faculty of 1000 evaluation for Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERβ and KLF5.
  73. Androgen-Induced Cell Migration: Role of Androgen Receptor/Filamin A Association
  74. Analysis of Androgen Receptor Rapid Actions in Cellular Signaling Pathways: Receptor/Src Association
  75. Targeting rapid action of sex steroid receptors in breast and prostate cancers
  76. Steroid signaling activation and intracellular localization of sex steroid receptors
  77. Cross talk between epidermal growth factor (EGF) receptor and extra nuclear steroid receptors in cell lines
  78. Faculty of 1000 evaluation for c-Abl regulates estrogen receptor alpha transcription activity through its stabilization by phosphorylation.
  79. Cell proliferation regulated by estradiol receptor: Therapeutic implications
  80. Faculty of 1000 evaluation for miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.
  81. Prostate cancer stem cells: the role of androgen and estrogen receptors
  82. Non-Genomic Action of Sex Steroid Hormones
  83. Signaling-dependent nuclear export of estradiol receptor controls cell cycle progression in breast cancer cells
  84. Faculty of 1000 evaluation for A naturally occurring HER2 carboxy-terminal fragment promotes mammary tumor growth and metastasis.
  85. Faculty of 1000 evaluation for Tumours with PI3K activation are resistant to dietary restriction.
  86. Sex-steroid hormones and EGF signalling in breast and prostate cancer cells: Targeting the association of Src with steroid receptors
  87. Hormone-dependent nuclear export of estradiol receptor and DNA synthesis in breast cancer cells
  88. Integrating signals between cAMP and MAPK pathways in breast cancer
  89. Inhibition of Estradiol Receptor/Src Association and Cell Growth by an Estradiol Receptor   Tyrosine-Phosphorylated Peptide
  90. Src-dependent signalling pathway regulation by sex-steroid hormones: Therapeutic implications
  91. Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth
  92. Crosstalk between EGFR and Extranuclear Steroid Receptors
  93. p85 regulatory subunit of PI3K mediates cAMP–PKA and estrogens biological effects on growth and survival
  94. Steroid Receptor Regulation of Epidermal Growth Factor Signaling through Src in Breast and Prostate Cancer Cells: Steroid Antagonist Action
  95. Role of Atypical Protein Kinase C in Estradiol-Triggered G1/S Progression of MCF-7 Cells
  96. Rapid signalling pathway activation by androgens in epithelial and stromal cells
  97. Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action
  98. Two Domains of the Progesterone Receptor Interact with the Estrogen Receptor and Are Required for Progesterone Activation of the c-Src/Erk Pathway in Mammalian Cells
  99. Interactions of Estrogen Receptors with Signal Cascade Molecules
  100. Sex steroid hormones act as growth factors
  101. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells
  102. cAMP signaling selectively influences Ras effectors pathways
  103. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis
  104. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor
  105. Protein Tyrosine Phosphorylation and Estradiol Action
  106. A 67 kDa non-hormone binding estradiol receptor is present in human mammary cancers
  107. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.
  108. Epidermal growth factor induces protein tyrosine phosphorylation and association of p190 with ras-GTP-ase activating protein in Caco-2 cells
  109. Properties of a purified estradiol-dependent calf uterus tyrosine kinase
  110. Phosphorylation and estradiol binding of estrogen receptor in hormone-dependent and hormone-independent GR mouse mammary tumors
  111. In vitro phosphorylation and hormone binding activation of the synthetic wild type human estradiol receptor
  112. Serine phosphorylation of biosynthetic pro-urokinase from human tumor cells
  113. Phosphorylation on Tyrosine ofin VitroSynthesized Human Estrogen Receptor Activates Its Hormone Binding
  114. In VitroInteraction of Estradiol Receptor with Ca2+-Calmodulin
  115. [54] Calmodulin-stimulated estradiol receptor-tyrosine kinase I
  116. Phosphorylation on tyrosine of oestradiol-17β receptor in uterus and interaction of oestradiol-17β and glucocorticoid receptors with antiphosphotyrosine antibodies
  117. Hormone regulation of 17β-estradiol receptor phosphorylation on tyrosine
  118. Activation-inactivation of hormone binding sites of the oestradiol-17β receptor is a multiregulated process
  119. Hypnosis for upper gastrointestinal endoscopy
  120. Direct evidence of in vitro phosphorylation-dephosphorylation of the estradiol-17β receptor. role of Ca2+-Calmodulin in the activation of hormone binding sites
  121. Phosphorylation-Dephosphorylation of the Estradiol Receptor Regulates its Hormone Binding Activity
  122. Phosphorylation of calf uterus 17β-estradiol receptor by endogenous Ca2+-stimulated kinase activating the hormone binding of the receptor
  123. Evidence that invivo estradiol receptor translocated into nuclei is dephosphorylated and released into cytoplasm
  124. Hormone binding of estradiol-17β receptor: Evidence for its regulation by cytoplasmic phosphorylation and nuclear dephosphorylation. Prevention of dephosphorylation by antiestrogens
  125. ATP-dependent enzyme activating hormone binding of estradiol receptor
  126. In vitro inactivation of oestrogen receptor by nuclei
  127. PHOSPHORYLATION ON TYROSINE OF THE 173-ESTRADIOL RECEPTOR